Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 08, 2022 at 04:20 pm EST
Reneo Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was USD 13.01 million compared to USD 12.74 million a year ago. Basic loss per share from continuing operations was USD 0.53 compared to USD 0.52 a year ago.
For the nine months, net loss was USD 38.36 million compared to USD 29.16 million a year ago. Basic loss per share from continuing operations was USD 1.57 compared to USD 1.82 a year ago.